MARKET

RCKT

RCKT

ROCKET PHARMACEU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.85
+0.80
+6.13%
After Hours: 13.85 0 0.00% 18:49 09/20 EDT
OPEN
13.03
PREV CLOSE
13.05
HIGH
13.94
LOW
12.93
VOLUME
578.32K
TURNOVER
--
52 WEEK HIGH
25.87
52 WEEK LOW
10.75
MARKET CAP
697.33M
P/E (TTM)
-7.4132
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RCKT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RCKT News

  • Blast Off With Rocket Pharmaceuticals
  • Seeking Alpha - Article.1d ago
  • Rocket Pharmaceuticals Announces Publication of Data from Phase 1/2 Trial of First-Generation RP-L102 for Fanconi Anemia in Nature Medicine
  • Business Wire.09/10 11:00
  • Rocket Pharma launches study of gene therapy for rare immunodeficiency disorder; shares up 5%
  • seekingalpha.09/05 19:31
  • Rocket Pharma Reports First Patient Treated In Phase 1/2 Registrational Trial Of RP-L201 For LAD-I
  • Benzinga.09/05 11:11

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapy treatment options for rare, devastating diseases. The Company’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The Company’s lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer. Its additional pipeline programs for bone marrow-derived disorders are for Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). The Company is also developing an AAV-based gene therapy program for pediatric heart failure indication, Danon disease.
More

Webull offers Rocket Pharmaceuticals Inc (RCKT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.